CompletedNot Applicable

Neurocognitive Follow-Up (FU) Study

Poland, Slovakia21 participantsStarted 2021-03-26

Plain-language summary

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).

Who can participate

Age range17 Months – 25 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Infants / children born prematurely who were enrolled into the original clinical trial and who are less than 24 m of CA.
✓. Having obtained his / her parents' (or his or her legally accepted guardian written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parent(s) / legal guardian has been informed of all pertinent aspects of the study.

What they're measuring

Bayley-III scores at 24 months

Timeframe: 24 months of CA

Trial details

NCT IDNCT04962035

SponsorSociété des Produits Nestlé (SPN)

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Cognitive Developmental Delay trials